Guest guest Posted August 25, 2008 Report Share Posted August 25, 2008 Note: forwarded message attached. Jeanne The Liver Update Donate now A Weekly Newsletter fromthe American Liver Foundation August 25, 2008 In This Issue - HCV Research - Fibrosis Protection - Telaprevir Trial - Nexavar Trial A Look at ALF Research:Dr. Lee Peng,MD, PhD Dr. Peng's study aims to use the principles of chemical biology to uncover novel antiviral compounds that may lead to more effective HCV treatments.Read more about Dr. Peng Walk for Fun...Walk for Life! Join ALF at a Liver Life Walk this fall and help raise awareness for liver disease.Find a Walk near you Find an ALF ChapterNear YouClick here Did you know?Hepatitis C is the number one reason for liver transplantation in the United States. To protect against liver disease, body puts cells 'under arrest' ScienceDaily, August 22, 2008 - A stable form of cell-cycle arrest known to offer potent protection against cancer also limits liver fibrosis, a condition characterized by an excess of fibrous tissue, according to a new report in the August 22nd Cell, a Cell Press publication.Read more Vertex to start Phase 3 trial of hepatitis drug Reuters, August 19, 2008 - Vertex Pharmaceuticals Inc said on Tuesday it has received regulatory approval to begin a late-stage trial of its experimental hepatitis C drug telaprevir in patients who have failed previous treatments.Read more Bayer starts phase III study on Nexavar as adjuvant liver cancer therapy Forbes, August 21, 2008 - Bayer said it has started enrolling patients in a phase III study on its cancer pill Nexavar, jointly developed with Onyx Pharmaceuticals Inc., as a liver cancer treatment in patients whose tumours have been surgically removed.Read more Thank you for your continued support of the American Liver Foundation. For more information on liver disease or our work as an organization, please visit our Web site or contact your local ALF chapter.Give to ALF today. Forward email This email was sent to jeanne2113@... by asu@.... Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | Privacy Policy. Email Marketing by American Liver Foundation | 75 Maiden Lane | Suite 603 | NEW YORK | NY | 10005 Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.